KALA BIO, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
KALA BIO, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2021 to Q3 2024.
  • KALA BIO, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.04M, a 1690% increase year-over-year.
  • KALA BIO, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $2.18M.
  • KALA BIO, Inc. annual Nonoperating Income (Expense) for 2023 was -$2.54M, a 107% decline from 2022.
  • KALA BIO, Inc. annual Nonoperating Income (Expense) for 2022 was $36.9M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.18M $1.04M +$980K +1690% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.2M $26K +$840K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $360K $124K +$2.9M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$2.54M $992K +$3.58M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$6.12M $58K -$43.6M -99.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $37.5M -$814K +$1.33M +61.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $36.1M -$2.77M -$745K -36.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $36.9M -$2.59M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $43.6M +$45.7M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$2.14M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$2.03M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 -$2.06M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.